Comments
Loading...

Beam Therapeutics Earnings Estimates

BEAMNASDAQ
Logo brought to you by Benzinga Data
$27.09
0.752.85%
Q4 2024 Earnings were released on Tue Feb 25th, before the market open

Beam Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BEAM | Benzinga

Beam Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 6
EPS Estimate
$-1.280
Quarterly Revenue Estimate
$13.20M
Annual Revenue
(as of Dec 31)
$63.52M

Analyze the earnings history of Beam Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Beam Therapeutics (BEAM) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42025-02-25$-1.09$-1.2814.8 %
Q32024-11-05$-1.17$-1.16-0.86 %
Q22024-08-06$-1.11$-1.142.63 %
Q12024-05-07$-1.21$-1.4214.8 %

Beam Therapeutics (BEAM) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42025-02-25$30.07M$15.12M98.9 %
Q32024-11-05$14.27M$14.50M-1.59 %
Q22024-08-06$11.77M$13.73M-14.3 %
Q12024-05-07$7.41M$16.97M-56.3 %

FAQ

Q

When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?

A

Beam Therapeutics (BEAM) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Beam Therapeutics (NASDAQ:BEAM)?

A

The Actual EPS was $-1.09, which beat the estimate of $-1.28.

Q

What were Beam Therapeutics’s (NASDAQ:BEAM) revenues?

A

The Actual Revenue was $30.1M, which beat the estimate of $15.1M.

Browse earnings estimates, EPS, and revenue on all stocks.